Comments to FDA: Determining Whether Human Research Studies Can Be Conducted Without an IND

Share page:
Docket Number:
FDA-2010-D-0503

Comments regarding guidance for clinical investigators, sponsors, and institutional review boards on investigational new drug applications—Determining whether human research studies can be conducted without an investigational new drug application.

Related Posts

CHPA Welcomes New Board Members at June Meeting